Biomarkers and Pharmacology

In the biomarker pipeline, the technologies that will enable the use of biomarkers in drug discovery and development vary depending on the research stage. The second stage, biomarker validation and clinical assay development, depends upon extremely sensitive and specific high-throughput immunoassays. The single greatest challenge in discovering biomarkers with clinical utility is the sensitivity and specificity necessary to determine that a biomarker is truly positive for disease or disease toxicodynamics, and can be used to detect deviations from normal. The molecular biomarkers conferences provide good exposure in drug discovery. Biomarkers have special applications in the areas of translational medicine, clinical development and safety assessment where they are put through several stages of drug discovery, development and validation.

  • Clinical Pharmacology
  • Environmental Pharmacology
  • Pharmacogenomics

Related Conference of Biomarkers and Pharmacology

Aug 21-22 2017

World Medical Laboratory Congress & Expo

San Francisco, USA
Aug 21-22, 2017

3rd International Conference on Autism

Los Angeles, USA
October 18-20, 2017

10th World Congress on Biomarkers & Clinical Research

Baltimore, USA
October 23-25, 2017

Medical Technology- 2017 (CME & CPD Accredited)

London, UK
October 23-25, 2017

Surgery- 2017 (CME & CPD Accredited)

London, UK
October 23-25, 2017

Ophthalmology- 2017 (CME & CPD Accredited)

London, UK
November 13-15, 2017

Neurology- 2017 (CME & CPD Accredited)

Valencia, Spain
November 13-15,2017

17th World Fitness Expo

(10 Plenary Forums - 1Event) Atlanta, USA
December 07-09, 2017

Biomedical- 2017 (CME & CPD Accredited)

Frankfurt, Germany

Biomarkers and Pharmacology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in